Jim Cramer Says AppFolio Is A 'Good One,' But Summit Therapeutics? 'Can't Go There'

On CNBC's “Mad Money Lightning Round,” Jim Cramer said Summit Therapeutics Inc. SMMT has no revenues. He added, “It's obviously just a very big spec. I can't go there.”

However, HC Wainwright & Co. analyst Mitchell Kapoor, on Jan. 21, reiterated Summit Therapeutics with a Buy and maintained a $44 price target.

This Financial Company Is ‘Good’

Cramer said HSBC Holdings plc HSBC is a “good” company, but added that he would recommend Banco Santander, S.A. SAN if he is going to buy one of those that's a foreign bank.

HSBC, meanwhile, on Jan.6, named Lisa McGeough as President and CEO for the United States.

Tech Stocks In Focus

When asked about Western Digital Corporation WDC, he said, “I have read so many upgrades of Western Digital that I have to believe the stock is way too cheap.”

On the earnings front, Western Digital, on Jan. 29, reported better-than-expected second-quarter revenue results.

AppFolio, Inc. APPF is a “cheap” stock, and it's a “good one,” Cramer said. “That one rocks.”

AppFolio, on Jan. 30, also reported better-than-expected sales results for its fourth quarter.

The Mad Money host said he doesn't want to sell Adobe Inc. ADBE down here. He added, “I know that it seems like a tough stock to own. I can't sell at 21 times earnings.”

However, Deutsche Bank analyst Brad Zelnick, on Jan. 8, downgraded Adobe from Buy to Hold and lowered the price target from $600 to $475.

Price Action:

• HSBC shares fell 0.5% to settle at $52.43 on Friday.
• Summit Therapeutics shares fell 3.9% to close at $21.50 during the session.
• Western Digital shares fell 1% to settle at $65.13.
• AppFolio shares dipped 7.8% to close at $233.91 on Friday.
• Adobe shares fell 1.9% to settle at $437.45.

Read Next:

• Wall Street’s Most Accurate Analysts Give Their Take On 3 Energy Stocks Delivering High-Dividend Yields

Image: Shutterstock